Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714323 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,359
- Enrollment target
NCT01714323: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01714323 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,359 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01714323, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,359 participants
- Enrollment target
Study Summary
Cigarette smoking is the leading preventable cause of death in the U.S. The 2008 US Public Health Service Smoking Cessation Guideline recommends offering effective treatment to smokers in all health care settings, including hospitals. Nearly 4 million smokers are hospitalized each year, and hospital admission offers a "teachable moment" for intervention. Hospital-initiated smoking cessation intervention is effective, but only if contact continues for more than 1 month after discharge. The challenge is to translate this research into clinical practice by identifying an evidence-based cost-effective model that U.S. hospitals can adopt. The major barrier is sustaining contact after discharge. This project tests an innovative strategy to streamline the delivery and maximize the uptake of post-discharge smoking interventions. Specific Aim: To test the effectiveness of an innovative strategy to maximize smokers' use of evidence-based tobacco treatment (counseling and medication) after hospital discharge, thereby increasing the proportion of smokers who achieve long-term (6-month) tobacco abstinence. Study Design: A multi-site randomized controlled comparative effectiveness trial will enroll 1350 adult smokers admitted to 3 acute care hospitals in Massachusetts and Pennsylvania. All subjects will receive a brief in-hospital smoking intervention and be randomly assigned at discharge to either Standard Care (passive referral to their state quitline) or Extended Care, a 3-month program consisting of (1) Free Medication: A 30-day supply of FDA-approved medication (nicotine replacement, bupropion, or varenicline) given at hospital discharge and refillable for a total of 90 days to encourage medication use and adherence; (2) Interactive Voice Response (IVR) Triage to Telephone Counseling from a national quitline provider. IVR aims to encourage medication adherence and enhance counseling efficiency by identifying smokers who need post-discharge support. Immediate transfer of a
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Sustained Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,359 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714323
The ClinicalTrials.gov registry entry for NCT01714323 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,359 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT01714323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714323 about?
NCT01714323 is a clinical study titled "Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers". Cigarette smoking is the leading preventable cause of death in the U.S. The 2008 US Public Health Service Smoking Cessation Guideline recommends offering effective treatment to smokers in all health care settings, including hospitals. Nearly 4 million smokers are hospitalized each year, and hospital...
What is the current status of trial NCT01714323?
This trial is currently completed. It is a NA study. The enrollment target is 1,359 participants. The study started on 2012-12. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01714323?
The interventions under investigation include: Standard Care (BEHAVIORAL), Sustained Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT01714323?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.